According to the study of Li et al. [16], abnormal apelin-ACE2 and SGLT2 (sodium-glucose cotransporter 2) signaling contributes to adverse cardiorenal injuries in patients with COVID-19. This evidence concerns the gene SLC5A2 and COVID-19.